200,000 doses of Novavax JN. 1 COVID-19 vaccine available from Jan. 1

The Taiwan Centers for Disease Control (CDC) on Friday announced that it will make 200,000 doses of protein-based vaccine targeting the JN. 1 subvariant of COVID-19 available to the general public from Jan. 1.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)